Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies
Clinical trial NCT05237206 · COMPLETED
Trial details
- NCT number
- NCT05237206
- Sponsor
- Alloplex Biotherapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2024-07-23
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.